These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

114 related articles for article (PubMed ID: 6752035)

  • 41. Murine monoclonal antibody elicited with antibiotic-exposed Escherichia coli exerts protective capacity in experimental bacterial infections.
    Lun MT; Amatucci AM; Raponi G; Filadoro F; Bartolazzi A; Fraioli R; Natali PG; Mancini C
    J Med Microbiol; 1994 Sep; 41(3):179-83. PubMed ID: 8064837
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Escherichia coli antibodies in opsonisation and protection against infection.
    van Dijk WC; Verbrugh HA; van Erne-van der Tol ME; Peters R; Verhoef J
    J Med Microbiol; 1981 Nov; 14(4):381-9. PubMed ID: 7031250
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Antigenic and immunogenic characteristics of subcellular fractions and whole cells of a rough E. coli 0111 (J5) mutant.
    Sakulramrung R; Domingue GJ
    Immunobiology; 1985 May; 169(4):372-88. PubMed ID: 2408995
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Anticore endotoxin F(ab')2 equine immunoglobulin fragments protect against lethal effects of gram-negative bacterial sepsis.
    Dunn DL; Mach PA; Condie RM; Cerra FB
    Surgery; 1984 Aug; 96(2):440-6. PubMed ID: 6379963
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Passive immunotherapy in neonatal calves--II. The efficacy of a J5 Escherichia coli hyperimmune plasma as immunotherapy in neonatal calves.
    Selim SA; Holmberg CA; Cullor JS
    Vaccine; 1995; 13(15):1454-9. PubMed ID: 8578826
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Therapeutic effectiveness of bacteriophages in the rescue of mice with extended spectrum beta-lactamase-producing Escherichia coli bacteremia.
    Wang J; Hu B; Xu M; Yan Q; Liu S; Zhu X; Sun Z; Tao D; Ding L; Reed E; Gong J; Li QQ; Hu J
    Int J Mol Med; 2006 Feb; 17(2):347-55. PubMed ID: 16391836
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Maternal vaccination with a fimbrial tip adhesin and passive protection of neonatal mice against lethal human enterotoxigenic Escherichia coli challenge.
    Luiz WB; Rodrigues JF; Crabb JH; Savarino SJ; Ferreira LC
    Infect Immun; 2015 Dec; 83(12):4555-64. PubMed ID: 26371126
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Mortality in swine herds endemically infected with Haemophilus pleuropneumoniae: effect of immunization with cross-reacting lipopolysaccharide core antigens of Escherichia coli.
    Fenwick BW; Osburn BI; Cullor JS; Henry SC; Olander HI
    Am J Vet Res; 1986 Sep; 47(9):1888-91. PubMed ID: 3532872
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Human IgG but not IgM antibodies can protect mice from the challenge with live O6 Escherichia coli.
    Pontes GN; Massironi SG; Arslanian C; Palmeira P; Carneiro-Sampaio MM; Nagao AT
    Scand J Immunol; 2005 Oct; 62(4):353-60. PubMed ID: 16253122
    [TBL] [Abstract][Full Text] [Related]  

  • 50. LEE-encoded regulator (Ler) mutants elicit serotype-specific protection, but not cross protection, against attaching and effacing E. coli strains.
    Zhu C; Feng S; Yang Z; Davis K; Rios H; Kaper JB; Boedeker EC
    Vaccine; 2007 Feb; 25(10):1884-92. PubMed ID: 17234305
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Treatment of E. coli and klebsiella bacteremia in agranulocytic animals with antiserum to a UDP-gal epimerase-deficient mutant.
    Ziegler EJ; Douglas H; Sherman JE; Davis CE; Braude AI
    J Immunol; 1973 Aug; 111(2):433-8. PubMed ID: 4577881
    [No Abstract]   [Full Text] [Related]  

  • 52. Treatment of gram-negative bacteremia with antiserum to mutant E. coli.
    Tierney WM
    N Engl J Med; 1983 Apr; 308(17):1032. PubMed ID: 6339930
    [No Abstract]   [Full Text] [Related]  

  • 53. Relative opsonic and protective activities of antibodies against K1, O and lipid A antigens of Escherichia coli.
    Welch WD; Martin WJ; Stevens P; Young LS
    Scand J Infect Dis; 1979; 11(4):291-301. PubMed ID: 93778
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Immunization with antibodies that mimic LPS protects against gram negative bacterial sepsis.
    Klaerner HG; Dahlberg PS; Acton RD; Battafarano RJ; Uknis ME; Johnston JW; Dunn DL
    J Surg Res; 1997 May; 69(2):249-54. PubMed ID: 9224390
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Effect of immune serum or polymyxin B on Escherichia coli-induced inflammation and vascular injury.
    Issekutz AC; Bhimji S; Bortolussi R
    Infect Immun; 1982 May; 36(2):548-57. PubMed ID: 6282752
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Rabbit pasteurellosis: induced disease and vaccination.
    Al-Lebban ZS; Corbeil LB; Coles EH
    Am J Vet Res; 1988 Mar; 49(3):312-6. PubMed ID: 3282457
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Antibodies to lipopolysaccharides after immunization of humans with the rough mutant Escherichia coli J5.
    Baumgartner JD; Heumann D; Calandra T; Glauser MP
    J Infect Dis; 1991 Apr; 163(4):769-72. PubMed ID: 2010630
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Protective effect of Salmonella typhimurium Re-LPS antiserum.
    Yu X; Yu Q
    Chin Med Sci J; 1993 Sep; 8(3):151-6. PubMed ID: 8142630
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Endotoxemia in neonatal calves given antiserum to a mutant Escherichia coli (J-5).
    Morris DD; Cullor JS; Whitlock RH; Wickstrom M; Corbeil LB
    Am J Vet Res; 1986 Dec; 47(12):2554-65. PubMed ID: 3541706
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Experimental Escherichia coli peritonitis in immunosuppressed mice: the role of specific and non-specific immunity.
    Vuopio-Varkila J
    J Med Microbiol; 1988 Jan; 25(1):33-9. PubMed ID: 3275782
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.